explore -WSS

explore

author：hotspot 2025-10-01 04:10:05 - browse：7381

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Vertex non

leisure time

WSS

What we need to know about Arena Bioworks

Flagship Pioneering launches a new biotech in two countries

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Despite FDA concern, risk that CAR

ReNAgade cuts staff seven months after raising $300 million

The EPA's new lead rule: How one expert crunched the numbers

hotspot

explore

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Affirmative action in medical school literally saved lives

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

General Catalyst, Summa Health deal will turn on physician buy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

BIO selects John Crowley as new CEO

Novavax promises a turnaround & Lilly roils the obesity market

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

hotspot

Apple Vision Pro: A first look at health apps on the new VR headset

Apple Vision Pro: A first look at health apps on the new VR headset

Quicker fix for pulse oximeters urged during FDA public meeting

Flagship Pioneering launches a new biotech in two countries

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Even great ERs can’t make up for American health disparities

focus

hotspot

leisure time

leisure time